Literature DB >> 33708435

A novel mono-modality fusion imaging method based on three-dimensional contrast-enhanced ultrasound for the evaluation of ablation margins after microwave ablation of hepatocellular carcinoma.

Jianmin Ding1,2,3, Dong Wang1,3, Yan Zhou1,3, Lin Zhao1,3, Hongyu Zhou1,3, Xiang Jing1,3, Yandong Wang1,3.   

Abstract

BACKGROUND: To investigate the feasibility and accuracy of using preoperative and postoperative three-dimensional contrast-enhanced ultrasound (3D CEUS) fusion imaging in the evaluation of safety margins after thermal ablation of hepatocellular carcinoma (HCC).
METHODS: A total of the 24 patients with HCC who underwent microwave ablation (MWA) between June 2020 and December 2020 were enrolled in this study. All patients received preoperative and postoperative 3D CEUS. The preoperative and postoperative 3D CEUS images were then fused. The success rate and evaluation time were recorded. The ablation margin and whether or not the safety margin was reached were calculated and recorded. If the ablation safety margin was not reached, the residual ablation volume needed to cover the safety margin was calculated automatically. The agreement between contrast-enhanced computed tomography(CECT) and 3D CEUS fusion imaging in the evaluation of ablation margins was explored using the kappa coefficient.
RESULTS: The 3D CEUS fusion success rate was 95.8% (23/24), with a mean fusion time of (4.1±1.8) minutes. Twenty-three tumors were completely ablated, and the safety margin was achieved for 9 tumors. The ablation margin of 14 tumors was <5 mm. The mean uncovered safety margin volume was (2.27±2.11) mL, and the mean proportion of the uncovered safety margin to the whole safety margin was 16.8%. According to the results of preoperative and postoperative CECT fusion imaging, the ablation margin of 13 tumors was <5 mm, and the ablation margin of 10 tumors was >5 mm. The 2 methods showed excellent consistency, with a Kappa value of 0.911 (P=0.000012).
CONCLUSIONS: This study has presented a novel mono-modality fusion imaging method based on CEUS. We demonstrated that 3D CEUS fusion has a short fusion time and a high success rate, as well as good consistency with enhanced CT fusion. Therefore, 3D CEUS fusion is a feasible and accurate tool for evaluating the immediate efficacy of thermal ablation of HCC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Three-dimensional contrast-enhanced ultrasound fusion imaging (3D CEUS fusion imaging); ablation margin; hepatocellular carcinoma (HCC); thermal ablation

Year:  2021        PMID: 33708435      PMCID: PMC7944154          DOI: 10.21037/jgo-21-46

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  27 in total

1.  Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching.

Authors:  Shigeo Shimose; Masatoshi Tanaka; Hideki Iwamoto; Takashi Niizeki; Tomotake Shirono; Hajime Aino; Yu Noda; Naoki Kamachi; Shusuke Okamura; Masahito Nakano; Ryoko Kuromatsu; Takumi Kawaguchi; Atsushi Kawaguchi; Hironori Koga; Yoshinori Yokokura; Takuji Torimura
Journal:  Hepatol Res       Date:  2019-05-13       Impact factor: 4.288

Review 2.  Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature.

Authors:  Marco Calandri; Giovanni Mauri; Steven Yevich; Carlo Gazzera; Domenico Basile; Marco Gatti; Andrea Veltri; Paolo Fonio
Journal:  Cardiovasc Intervent Radiol       Date:  2019-02-26       Impact factor: 2.740

3.  Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors.

Authors:  Erjiao Xu; Yinglin Long; Kai Li; Qingjing Zeng; Lei Tan; Liping Luo; Qiannan Huang; Rongqin Zheng
Journal:  Int J Hyperthermia       Date:  2018-10-09       Impact factor: 3.914

4.  Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging.

Authors:  Er-Jiao Xu; Shu-Min Lv; Kai Li; Ying-Lin Long; Qing-Jing Zeng; Zhong-Zhen Su; Rong-Qin Zheng
Journal:  Int J Hyperthermia       Date:  2017-09-10       Impact factor: 3.914

5.  Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns.

Authors:  Yusuke Okuwaki; Takahide Nakazawa; Akitaka Shibuya; Koji Ono; Hisashi Hidaka; Masaaki Watanabe; Shigehiro Kokubu; Katsunori Saigenji
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

6.  Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.

Authors:  Jieyi Ye; Guangliang Huang; Xiaoer Zhang; Ming Xu; Xiaoyu Zhou; Manxia Lin; Xiaohua Xie; Xiaoyan Xie
Journal:  Int J Hyperthermia       Date:  2018-11-16       Impact factor: 3.914

7.  Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.

Authors:  Tae Wook Kang; Hyo Keun Lim; Min Woo Lee; Young-sun Kim; Dongil Choi; Hyunchul Rhim
Journal:  Radiology       Date:  2013-11-22       Impact factor: 11.105

8.  Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.

Authors:  Jianmin Ding; Lei Long; Xiang Zhang; Chen Chen; Hongyu Zhou; Yan Zhou; Yandong Wang; Xiang Jing; Zhaoxiang Ye; Fengmei Wang
Journal:  Eur Radiol       Date:  2020-08-15       Impact factor: 5.315

9.  Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors.

Authors:  J Ding; X Jing; Y Wang; F Wang; Y Wang; Z Du
Journal:  Clin Radiol       Date:  2016-08-07       Impact factor: 2.350

10.  Intra-Procedural CT/MR-Ultrasound Fusion Imaging Helps to Improve Outcomes of Thermal Ablation for Hepatocellular Carcinoma: Results in 502 Nodules.

Authors:  Erjiao Xu; Kai Li; Yinglin Long; Liping Luo; Qingjing Zeng; Lei Tan; Xuqi He; Qiannan Huang; Yuxuan Wu; Rongqin Zheng
Journal:  Ultraschall Med       Date:  2019-10-31       Impact factor: 6.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.